RT Journal Article
SR Electronic
T1 Fast progression in non–small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001882
DO 10.1136/jitc-2020-001882
VO 9
IS 3
A1 Gandara, David
A1 Reck, Martin
A1 Moro-Sibilot, Denis
A1 Mazieres, Julien
A1 Gadgeel, Shirish
A1 Morris, Stefanie
A1 Cardona, Andres
A1 Mendus, Diana
A1 Ballinger, Marcus
A1 Rittmeyer, Achim
A1 Peters, Solange
YR 2021
UL http://jitc.bmj.com/content/9/3/e001882.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.